-
Taxonomy & unit
-
ratio: %
-
Description
-
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
-
Summary
-
Vitaspring Biomedical Co. Ltd. quarterly Debt-to-equity history and growth rate from Q1 2018 to Q3 2022.
- Vitaspring Biomedical Co. Ltd. Debt-to-equity for the quarter ending October 31, 2022 was 63.4 %, a 12.2% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)